{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:17:35Z","timestamp":1795033055833,"version":"4.10.2"},"reference-count":44,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.3201\/eid3110.250359","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:50:21Z","timestamp":1759269021000},"source":"Crossref","is-referenced-by-count":3,"title":["Recent Systemic Antifungal Exposure and Nonsusceptible\n                    <i>Candida<\/i>\n                    in Hospitalized Patients, South Africa, 2012\u20132017"],"prefix":"10.3201","volume":"31","author":[{"given":"Charlotte","family":"Rabault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliwe","family":"Shuping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Mpembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Paccoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelesh P.","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for GERMS-SA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-1","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease.","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3201\/eid2706.210128","article-title":"HIV infection as risk factor for death among hospitalized persons with candidemia, South Africa, 2012\u20132017.","volume":"27","author":"Govender","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/INF.0000000000003151","article-title":"for GERMS-SA. Epidemiology of culture-confirmed candidemia among hospitalized children in South Africa, 2012-2017.","volume":"40","author":"Shuping","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-4","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis.","volume":"73","author":"Lamoth","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses.","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-6","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY Antifungal Surveillance Program: results for Candida species from 1997\u20132016.","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-7","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/jac\/dkw091","article-title":"Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa.","volume":"71","author":"Govender","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-8","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3201\/eid2509.190040","article-title":"GERMS-SA. Epidemiologic shift in candidemia driven by Candida auris, South Africa, 2016\u20132017.","volume":"25","author":"van Schalkwyk","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-9","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3201\/eid2411.180368","article-title":"Candida auris in South Africa, 2012-2016.","volume":"24","author":"Govender","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-10","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/j.1469-0691.2010.03208.x","article-title":"Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain.","volume":"16","author":"Rodr\u00edguez","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jinf.2015.09.041","article-title":"Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.","volume":"72","author":"Bailly","year":"2016","journal-title":"J Infect"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-13","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-14","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.","volume":"65","author":"Slavin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-15","doi-asserted-by":"publisher","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/jac\/35.1.103","article-title":"Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.","volume":"35","author":"Johnson","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/jof8090931","article-title":"Pan-echinocandin resistant C. parapsilosis harboring an F652S Fks1 alteration in a patient with prolonged echinocandin therapy.","volume":"8","author":"Siopi","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-18","doi-asserted-by":"crossref","unstructured":"Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, Beldavs ZG,  Epidemiology and risk factors for echinocandin nonsusceptible\n                      Candida glabrata\n                      bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008\u20132014. Open Forum Infect Dis. 2015;2:ofv163. 10.1093\/ofid\/ofv163","DOI":"10.1093\/ofid\/ofv163"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s15010-018-1139-z","article-title":"Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period.","volume":"46","author":"Mencarini","year":"2018","journal-title":"Infection"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/jof8020100","article-title":"A Brazilian interhospital candidemia outbreak caused by fluconazole-resistant Candida parapsilosis in the COVID-19 era.","volume":"8","author":"Thomaz","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-21","doi-asserted-by":"publisher","first-page":"e0113022","DOI":"10.1128\/aac.01130-22","article-title":"Hospital clonal outbreak of fluconazole-resistant Candida parapsilosis harboring the Y132F ERG11p substitution in a French intensive care unit.","volume":"67","author":"Presente","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-22","doi-asserted-by":"publisher","first-page":"106592","DOI":"10.1016\/j.ijantimicag.2022.106592","article-title":"Genetic relatedness among azole-resistant Candida tropicalis clinical strains in Taiwan from 2014 to 2018.","volume":"59","author":"Zhou","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s40265-022-01751-x","article-title":"Global consumption trend of antifungal agents in humans from 2008 to 2018: data from 65 middle- and high-income countries.","volume":"82","author":"Pathadka","year":"2022","journal-title":"Drugs"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jof3030041","article-title":"Strategies to reduce mortality in adult and neonatal candidemia in developing countries.","volume":"3","author":"Kaur","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-26","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-27","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/S2666-5247(21)00190-7","article-title":"The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey.","volume":"3","author":"Driemeyer","year":"2022","journal-title":"Lancet Microbe"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-28","doi-asserted-by":"publisher","first-page":"ii5","DOI":"10.1093\/jac\/dkw391","article-title":"The current treatment landscape: the need for antifungal stewardship programmes.","volume":"71","author":"Mu\u00f1oz","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-29","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antifungal susceptibility testing of yeasts, 3rd ed. Supplement M27M44S. Wayne (PA): The Institute; 2022."},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-30","unstructured":"Centers for Disease Control and Prevention. Antifungal susceptibility testing for\n                      C. auris\n                      .\n                      2024 [cited 2024 Jun 12]. https:\/\/www.cdc.gov\/candida-auris\/hcp\/laboratories\/antifungal-susceptibility-testing.html"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-31","unstructured":"Kranker K. dtalink: Faster probabilistic record linking and deduplication methods in Stata for large data files. Presented at: 2018 Stata Conference; Columbus, OH, USA; 2018 Jul 19\u201320."},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-32","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/jac\/dkq136","article-title":"Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?","volume":"65","author":"Oxman","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-33","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/01.CCM.0000259379.97694.00","article-title":"Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.","volume":"35","author":"Shorr","year":"2007","journal-title":"Crit Care Med"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-34","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1128\/AAC.00690-11","article-title":"Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.","volume":"55","author":"Blanchard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-35","unstructured":"Husna I. Changing distribution of\n                      Candida\n                      species causing bloodstream infections in SA 2019 to 2021. National Institute for Communicable Diseases. 2022 [cited 2024 Sep 13]. http:\/\/www.nicd.ac.za\/wp-content\/uploads\/2022\/08\/Changing-distribution-of-Candida-species-causing-bloodstream-infections-in-SA-2019-to-2021.pdf"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-36","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1128\/AAC.00262-08","article-title":"A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.","volume":"52","author":"Garcia-Effron","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-37","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3201\/eid2407.171087","article-title":"Large outbreaks of fungal and bacterial bloodstream infections in a neonatal unit, South Africa, 2012\u20132016.","volume":"24","author":"van Schalkwyk","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/INF.0b013e318170bb0c","article-title":"Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.","volume":"27","author":"Manzoni","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-39","doi-asserted-by":"publisher","first-page":"101110","DOI":"10.1016\/j.mycmed.2020.101110","article-title":"High colonization by Candida parapsilosis sensu stricto on hands and surfaces in an adult intensive care unit.","volume":"31","author":"da Silva","year":"2021","journal-title":"J Mycol Med"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/jof7040259","article-title":"Environmental clonal spread of azole-resistant Candida parapsilosis with Erg11-Y132F mutation causing a large candidemia outbreak in a Brazilian cancer referral center.","volume":"7","author":"Thomaz","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/myc.13070","article-title":"Fluconazole-resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa.","volume":"63","author":"Magobo","year":"2020","journal-title":"Mycoses"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-42","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/jac\/dkad112","article-title":"Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis.","volume":"78","author":"Daneshnia","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-43","unstructured":"The National Department of Health. Standard treatment guidelines and essential medicines list for South Africa. Paediatric hospital level 2023 edition. Chapter 8.6. Candidiasis [cited 2025 Jun 30]. https:\/\/www.health.gov.za\/wp-content\/uploads\/2025\/06\/Paediatric-STGs-and-EML-2023-Edition-Updated-May-2025.pdf."},{"key":"key-10.3201\/eid3110.250359-202509031108-R-2-44","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1128\/JCM.00179-11","article-title":"Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia.","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/10\/25-0359_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:18:16Z","timestamp":1795029496000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/10\/25-0359_intro"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3110.250359","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}